IRIS
LUZZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.706
AS - Asia 2.083
EU - Europa 1.834
SA - Sud America 342
AF - Africa 36
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 8.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.560
SG - Singapore 1.018
IT - Italia 712
CN - Cina 587
DE - Germania 347
BR - Brasile 276
GB - Regno Unito 251
SE - Svezia 153
FI - Finlandia 141
VN - Vietnam 115
CA - Canada 114
IN - India 93
NL - Olanda 66
IR - Iran 56
HK - Hong Kong 38
JP - Giappone 31
AR - Argentina 28
BD - Bangladesh 28
TR - Turchia 27
RU - Federazione Russa 25
PL - Polonia 23
MX - Messico 22
ES - Italia 18
AU - Australia 17
ID - Indonesia 16
CZ - Repubblica Ceca 14
TW - Taiwan 14
UA - Ucraina 14
FR - Francia 13
IQ - Iraq 11
ZA - Sudafrica 11
IL - Israele 10
EC - Ecuador 9
PK - Pakistan 9
RO - Romania 9
AT - Austria 7
CL - Cile 7
IE - Irlanda 7
EG - Egitto 6
EU - Europa 6
PE - Perù 6
RS - Serbia 6
UY - Uruguay 6
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
MA - Marocco 4
OM - Oman 4
PH - Filippine 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
CH - Svizzera 3
CO - Colombia 3
GR - Grecia 3
HU - Ungheria 3
KE - Kenya 3
LT - Lituania 3
MG - Madagascar 3
NG - Nigeria 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BE - Belgio 2
CI - Costa d'Avorio 2
CU - Cuba 2
DK - Danimarca 2
JM - Giamaica 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 8.028
Salva come PNG Salva come JPEG
Città #
Chandler 533
Singapore 467
Dallas 308
Munich 292
Santa Clara 292
Hefei 274
Milan 243
Chicago 228
Princeton 211
Lawrence 210
London 202
Wilmington 132
Ashburn 107
Ottawa 82
Helsinki 80
Des Moines 68
Los Angeles 47
Boardman 46
Turku 43
Ho Chi Minh City 42
Shanghai 38
São Paulo 37
Rome 35
Catanzaro 33
Guangzhou 29
Naples 29
Hong Kong 28
New York 27
Redwood City 27
Hanoi 23
Cittanova 22
Hanover 22
Pune 22
Mumbai 19
Norwalk 19
San Francisco 17
Beijing 16
Council Bluffs 16
Phoenix 16
Redmond 16
Brooklyn 15
Warsaw 15
Palermo 14
The Dalles 14
Tokyo 14
Montreal 13
Shenzhen 13
Bari 12
Istanbul 12
Mendicino 12
Osaka 12
Stockholm 12
Dhaka 11
Jyväskylä 11
Chennai 10
San Nicola Manfredi 10
Atlanta 9
Boston 9
Cosenza 9
Olomouc 9
Praia A Mare 9
Amsterdam 8
Charlotte 8
Curitiba 8
Jiaxing 8
Tehran 8
Brasília 7
Collegeville 7
Dublin 7
Ankara 6
Assago 6
Belo Horizonte 6
Central 6
Haiphong 6
Horia 6
Jerusalem 6
Johannesburg 6
Vienna 6
Wuhan 6
Buffalo 5
Clearwater 5
Da Nang 5
Hangzhou 5
Maletto 5
Montevideo 5
Nanjing 5
Reggio Calabria 5
Rio de Janeiro 5
Salvador 5
Siena 5
Taipei 5
Toronto 5
Wuxi 5
Zabki 5
Ann Arbor 4
Arequipa 4
Belgrade 4
Boydton 4
Campinas 4
Elk Grove Village 4
Totale 4.863
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 227
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 173
Dietary polyphenolsand non-alcoholic fatty liver disease 86
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 71
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 71
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 63
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 63
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 62
7-Ketolithocholic acid administration in man: effects on biliary lipid composition, serum bile acid pattern and evaluation of the cholelitholytic potential 61
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 60
The role of gluten-free diet in nonalcoholic fatty liver disease development 60
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopiche di mucosa gastrica antrale 57
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 57
Antral nodularity identifies Helicobacter pylori infected children with higher grades of gastric inflammation 56
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials 55
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopicher di mucosa gastrica antrale 55
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 55
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 54
Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity 54
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 54
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 52
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 51
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 50
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 49
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 49
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation 49
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 49
Ancient wheats: beneficial effects on insulin resistance 48
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 47
Bioactive interleukin-18 expression is up-regulated in Crohn’s disease 47
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 47
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 47
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 46
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 46
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 45
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 45
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 44
Antibacterial drugs in Crohn's disease 44
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 43
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 43
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 43
Applications of Text Mining techniques to extract meaningful information from gastroenterology medical reports 42
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 42
La calcolosi della colecisti 42
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 41
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathological features 41
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation 41
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 41
Ruolo della colonscopia e delle biopsie multiple nella sorveglianza dei pazienti affetti da colite ulcerosa di lunga durata 41
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 41
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 41
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 41
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 41
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 40
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 40
Bioactive IL-18 expression is up-regulated in Crohn's disease 40
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 40
Gut microbiota and non-alcoholic fatty liver disease 40
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 39
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study 39
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 39
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 39
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 38
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 38
Circulating D dimer in inflammatory bowel disease 38
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 38
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 38
Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacter Pylori infection 38
Colite ulcerosa: problemi di istopatologia 37
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 36
Bone mineralization in celiac disease 36
Gut microbiota changes and chronic hepatitis C virus infection 35
Low prevalence of p-ANCA in unaffected relatives of patients with ulcerative colitis from a Mediterranean area 35
Trattamento medico della litiasi colesterolica 35
Interazione Ospite-Batterio 35
Follow-up clinico-endoscopico in 32 casi di adenoma maligno del colon 34
Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area. 34
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 33
Changes in the mucosal expression of interleukin 15 in Helicobacter pylori associated gastritis 33
Hepatitis C virus-induced hepatocellular carcinoma: a narrative review 33
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 33
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 33
The therapy of cholesterol gallstones with bile acids 33
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 33
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 33
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 33
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission 32
Emorragia intestinale da diverticolo ulcerato del tenue. Descrizione di un caso clinico 32
Evidence favouring the gastro-oral route in the transmission of Helicobacter pylori infection in children. European Journal of Gastroenterology and Hepatology 32
The prevalence of Helicobacter pylori infection is not increased in children with celiac disease. 32
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 32
Author correction to Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells [Infect. Immun. 72, 9, (2004) 5019-5026] 32
Helicobacter pylori transmission and Hepatitis A 32
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 32
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 31
Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators 31
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 31
Gastriti acute e croniche 31
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 31
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 31
Totale 4.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 3 38 20 17 15 26 47 10 4 3
2021/2022568 13 11 16 108 54 8 20 135 54 40 89 20
2022/20231.896 426 60 72 159 186 146 31 151 291 194 147 33
2023/2024952 223 98 71 63 32 219 34 61 45 26 27 53
2024/20252.934 386 182 176 67 173 388 192 155 421 90 250 454
2025/20261.474 294 616 564 0 0 0 0 0 0 0 0 0
Totale 8.306